Gilead Sciences, Inc.

GILD · Moat type: REGULIERUNG

MoatScore

7/10

Fair Value

203 USD

Margin of Safety

+35.5 %

Rating

STARK

Gilead Sciences develops, manufactures, and markets antiviral medications—primarily for HIV, hepatitis C and B, as well as oncological indications—and generates revenues through patent-protected pharmaceutical sales as well as growing contributions from the oncology portfolio.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.